Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Stephen D Shafran

1-50 of 65 results

View this query on the Wikidata Query Service
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

scientific article published on November 16, 2015
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.

scientific article
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

scientific article published on 5 April 2017
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study

scientific article published on 30 July 2014
Management of chronic hepatitis C: consensus guidelines

scientific article published on June 2007
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection

scientific article
Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial.

scientific article published on June 2013
Safety and Immunogenicity of Glycoprotein D--Adjuvant Genital Herpes Vaccine

scientific article published on 24 March 2005
Management of chronic hepatitis B: consensus guidelines

scientific article published on June 2007
Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection

scientific article
Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes

scientific article published on 01 October 2018
Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial

scientific article published in April 2004
Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis

scientific article published in November 2017
Chronic hepatitis C virus management: 2000-2005 update

scientific article
Immunogenicity Is Not Improved by Increased Antigen Dose or Booster Dosing of Seasonal Influenza Vaccine in a Randomized Trial of HIV Infected Adults

scientific article published on March 25, 2011
HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials

scientific article published on June 9, 2015
Treatment of hepatitis C in HIV-coinfected patients

scientific article
Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial

scientific article
Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults

scientific article published on January 1, 2010
Early initiation of antiretroviral therapy: the current best way to reduce liver-related deaths in HIV/hepatitis C virus-coinfected patients

scientific article published on April 2007
Long-term persistence of HCV NS5A resistance associated substitutions after treatment with the HCV NS5A inhibitor, ledipasvir, without sofosbuvir

scientific article
Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir

scientific article published on 08 July 2013
Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.

scientific article
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study

scientific article published on 23 May 2017
Resistance Analysis in Patients with Genotype 1-6 HCV Infection Treated with Sofosbuvir/Velpatasvir in the Phase 3 Studies

scientific article published on 5 December 2017
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults

scientific article published on January 2013
Identification of 19 Novel Hepatitis C Virus Subtypes-Further Expanding HCV Classification

scientific article published on 22 February 2019
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment

scientific article published on 04 July 2016
The effect of current management on morbidity and mortality in hospitalised adults with funguria

scientific article published in October 2004
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis

scientific article published on 11 June 2019
Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials

scientific article
CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian guidelines for the treatment of hepatitis C infection in HIV-hepatitis C coinfected adults

scientific article
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1

scientific article published on March 2016
Hospitalization for community-acquired pneumonia in Alberta patients with human immunodeficiency virus infections: a case control study

scientific article published in July 2003
Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial.

scientific article
Hepatitis C and the sex trade

scientific article published on November 2015
The Hepatitis C Genotype 1 Paradox: Cost per Treatment Is Increasing, but Cost per Cure Is Decreasing

scientific article published on January 1, 2015
Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.

scientific article published on November 2004
Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen

scientific article published in September 2007
Nelfinavir and non-nucleoside reverse transcriptase inhibitor-based salvage regimens in heavily HIV pretreated patients

scientific article
Drug-drug interaction between itraconazole and the protease inhibitor lopinavir/ritonavir

scientific article published on 24 November 2009
Canadian consensus guidelines for the optimal use of maraviroc in the treatment of HIV-infected adults.

scientific article
Achievement of hepatitis C cascade of care milestones: a population-level analysis in Alberta, Canada

scientific article published on 20 June 2019
Prevalence and Correlates of HIV and Hepatitis B Virus Coinfection in Northern Alberta

scientific article published on January 1, 2014
Daclatasvir and sofosbuvir with ribavirin for 24 weeks in chronic hepatitis C genotype-3-infected patients with cirrhosis: a Phase III study (ALLY-3C)

scientific article published on 01 January 2019
Q93600303

article published in 2014
Planning HIV therapy to prevent future comorbidities: patient years for tenofovir alafenamide

scientific article published on 01 June 2019
Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment study

scientific article published on 27 February 2019
Response to Noe, Oldenbuettel and Jaeger

scientific article published on 18 December 2019
Challenges in Initiating Antiretroviral Therapy in 2010

scientific article published on August 1, 2010

Paulina is supported by:

About Paulina

Help